# Moderna

Moderna is an other based in Cambridge, United States.

## Overview

- **Organization type:** other
- **Headquarters:** Cambridge, United States
- **Region:** North America
- **Address:** Cambridge, MA, United States
- **Founded:** 2010
- **Assets under management:** Undisclosed
- **Website:** modernatx.com
- **LinkedIn:** https://www.linkedin.com/company/moderna

## Regulatory record

- **Reports private funds:** No

## About

Learn how we’re changing the world of medicine. Discover career opportunities, our product pipeline, and browse media resources. Meet Moderna.

## Sectors

- Digital Health
- Healthcare Services
- Biotech & Pharma

## Offices

- Leverkusen
- Greenwich
- Boston
- New York
- Seattle
- Princeton
- San Francisco
- Hellerup

## People

- Stéphane Bancel — Chief Executive Officer
- Noubar Afeyan — Co-Founder and Chairman
- Keke — Senior Director of People Analytics

## Questions

### Who runs investment decisions at Moderna?

Stéphane Bancel is CEO and leads corporate strategy. Board of directors, including co-founder Noubar Afeyan, governs major decisions. No separate investment committee structure is publicly comparable to a family office.

### How does Moderna source proprietary deal flow?

Moderna's pipeline is primarily internally developed through its mRNA platform, supplemented by licensing and academic partnerships. The company does not operate a venture capital-style sourcing model.

### Does Moderna participate in fund commitments or only direct deals?

Moderna does not function as an investment vehicle. It engages in partnerships and licensing arrangements, such as the collaboration with Merck for cancer vaccine development.

### What investment stages does Moderna typically target?

Moderna's development stages are clinical: preclinical through Phase 3 trials. Financial investment stages are not applicable; it is a drug developer, not an allocator.

### Which sectors does Moderna explicitly avoid?

Moderna focuses on mRNA-based medicines and does not explicitly state avoidance of sectors, but its pipeline excludes areas like medical devices or diagnostics beyond mRNA.

## Related profiles

- [Life Science Outsourcing](https://altss.com/profile/life-science-outsourcing)
- [Northgate](https://altss.com/profile/northgate)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/moderna

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology